Assessing patient accrual to cooperative group lung cancer trials: why are rates disappointing?
J Thorac Oncol
.
2011 Dec;6(12):1971-3.
doi: 10.1097/JTO.0b013e3182370deb.
Authors
Brian E Lally
,
Henry Wagner
,
Corey Langer
,
Charles R Thomas Jr
PMID:
22088986
DOI:
10.1097/JTO.0b013e3182370deb
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Non-Small-Cell Lung / therapy*
Clinical Trials as Topic
Humans
Lung Neoplasms / therapy*
Patient Selection*